Neurocrine Biosciences, Inc.
NASDAQ:NBIX · NASDAQ Global Select
-$0.71 today
Vol 2.40M · Avg 1.18M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+25.83%
Period High
$167.35
Period Low
$123.10
Latest
$158.29
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Viatris Inc.
NASDAQ:VTRS
$17.90B
Hologic, Inc.
HOLX
$16.97B
The Cooper Companies, Inc.
NASDAQ:COO
$12.85B
Smith & Nephew plc
NYSE:SNN
$12.74B
Elanco Animal Health Incorporated
NYSE:ELAN
$12.10B
ICON Public Limited Company
NASDAQ:ICLR
$11.18B
Dr. Reddy's Laboratories Limited
NYSE:RDY
$11.07B
Summit Therapeutics Inc.
NASDAQ:SMMT
$10.67B
Tempus AI, Inc.
NASDAQ:TEM
$8.87B
Universal Health Services, Inc.
NYSE:UHS
$8.83B
What is the latest NBIX filing?
The latest filing shown is 4 dated Jun 9, 2026.
How many recent filings does NBIX have?
Intrinsic Alpha currently shows 20 recent filings for NBIX.
Explore More
Continue the stock analysis
Jump to another research area for this company.